Supplemental material
Open access
9,320
Views
21
CrossRef citations to date
0
Altmetric
Review
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
Christina ClausRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-6316-5855View further author information
, https://orcid.org/0000-0001-6316-5855View further author information
Claudia Ferrara-KollerRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandView further author information
& Christian KleinRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandView further author information
Article: 2167189
|
Received 21 Jul 2022, Accepted 06 Jan 2023, Published online: 01 Feb 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.